Clinical trial
ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis
NCT07712835 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- April 30, 2025
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ecmo outcomes, hematopoetic stem cell transplant, malignancies, hematologic, respiratory failure (pediatric patients), solid tumor malignancies